Imidazo[2,1-b]benzothiazoles. I

DOI: 10.1248/cpb.36.4760

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 4760 - 4768 (1988)

Update date:2022-08-03

Topics:

Authors:

El-Shorbagi

Sakai Sakai

El-Gendy

Omar Omar

Farag Farag

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.36.4760

Full text of DOI:10.1248/cpb.36.4760

Products guided by the article

Product name:2-(2-Imino-benzothiazol-3-yl)-1-(4-methoxy-phenyl)-ethanone; hydrobromide

Cas No:99582-73-7

R&D Labs maybe for 99582-73-7

Beijing Cooperate Pharmaceutical Co.,Ltd

Contact:86-01060279497

Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
Zhejiang Newfine Industry Co.,Ltd.

Contact:+86-573-82262042

Address:No.225,Dongqing Road, garoms@163.com
Anhui Gusheng Import&Export CO.,LTD

Contact:86-551-63662296

Address:Jinzhai Road NO.162 ,hefei, china
chengdu firsterchem Pharmaceutical Co., Ltd.

Contact:028-66825849

Address:chengdu
Shenyang NovPharm Technology Co., Ltd.

Contact:.+86-24-24165786

Address:Room 306, Hongjin Mansion, No. 36-1, Wanliutang Rd., Shenhe District, Shenyang, Liaoning, P.R.C.

Relevant to this article

Doi:10.1021/ja01512a058
(1959)
Discovery of N-((1-(4-(3-(3-((6,7-Dimethoxyquinolin-3-yl)oxy)phenyl)ureido)-2-(trifluoromethyl)phenyl)piperidin-4-yl)methyl)propionamide (CHMFL-KIT-8140) as a Highly Potent Type II Inhibitor Capable of Inhibiting the T670I gatekeeper Mutant of cKIT Kinase

Doi:10.1021/acs.jmedchem.6b00902
(2016)
Doi:10.1021/ja01258a011
(1942)
An optimized procedure for direct access to 1: H -indazole-3-carboxaldehyde derivatives by nitrosation of indoles

Doi:10.1039/c8ra01546e
(2018)
Remarkable β-selectivity in the synthesis of β-1-C- arylglucosides: Stereoselective reduction of acetyl-protected methyl 1-C-arylglucosides without acetoxy-group participation

Doi:10.1021/jo071051i
(2007)
Doi:10.1016/S0040-4039(00)62045-2
(1962)

Article Doi